1. Home
  2. Our Firm
  3. News
  4. Chris Pasquale Joins Guggenheim Securities to Add Medical Supplies and Devices to Healthcare Coverage

Our Firm

May 03, 2016

Chris Pasquale Joins Guggenheim Securities to Add Medical Supplies and Devices to Healthcare Coverage

NEW YORK – Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Chris Pasquale has joined the equity research department covering the Medical Supplies and Devices sector.

Mr. Pasquale joined Guggenheim from J.P. Morgan, where he worked on the top-ranked medical supplies and devices team, according to the Institutional Investor Magazine 2015 Rankings.

“Chris is an outstanding addition to our strong and growing healthcare research team, bringing an important new dimension to our coverage,” said John Hervey, Director of Research at Guggenheim Securities. “Chris’ franchise will complement our established and widely recognized life sciences and healthcare policy coverage.”

Mr. Pasquale’s hire expands Guggenheim’s healthcare team to six senior professionals:

  • Tony Butler, PhD, Biopharma
  • Louise Chen, Specialty Pharmaceuticals
  • Chris Pasquale, Medical Supplies and Devices
  • Bill Tanner, PhD, Biotechnology
  • Eric Assaraf, Healthcare Policy
  • Rick Weissenstein, Healthcare Policy

“We are committed to high quality research, thought leadership, and unique events such as our recent Microbiome conference,” said Matthew Johnson, Head of Equities at Guggenheim Securities. “Chris’ hire builds on this commitment to healthcare, one of our core areas of focus for investors.”

Mr. Pasquale earned his B.S. at Duke University.


About Guggenheim Securities

Guggenheim Securities is the investment banking and capital markets business of Guggenheim Partners, a global investment and advisory firm. Guggenheim Securities offers a full range of services that fall into four broad categories: Advisory, Sales and Trading, Financing, and Research. Guggenheim Securities is headquartered in New York, with additional offices in Atlanta, Boston, Chicago, Los Angeles, and San Francisco. For more information, visit guggenheimpartners.com.

About Guggenheim Partners

Guggenheim Partners is a global investment and advisory firm with more than $240 billion1 in assets under management. Across our three primary businesses of investment management, investment banking, and insurance services, we have a track record of delivering results through innovative solutions. With 2,500 professionals based in more than 25 offices around the world, our commitment is to advance the strategic interests of our clients and to deliver long-term results with excellence and integrity. We invite you to learn more about our expertise and values by visiting GuggenheimPartners.com and following us on Twitter at twitter.com/guggenheimptnrs.

*Assets under management are as of 03.31.2016 and include consulting services for clients whose assets are valued at approximately $56bn.


Media Contact

Ellen Cunningham
Guggenheim Partners
212.518.9578
Ellen.N.Cunningham@GuggenheimPartners.com



July 17, 2018

Whitney Ijem Joins Guggenheim Securities as Biotech Analyst

Guggenheim Securities announced today that Whitney Ijem has joined the firm as a Director in a planned expansion of the Healthcare Research team. Ms. Ijem is focusing on the coverage of Biotech companies, working closely with the firm’s growing therapeutics team.

Read More

July 12, 2018

Guggenheim Securities Hires Jordan Bliss to Expand Healthcare Investment Banking Group

Guggenheim Securities, the investment banking and capital markets division of Guggenheim Partners, announced today that Jordan Bliss will join the firm as a Senior Managing Director in the firm’s Healthcare investment banking group. Mr. Bliss will focus on advising companies in the life sciences sector and will be based in Guggenheim’s San Francisco office.

Read More



© 2018 Guggenheim Partners, LLC. All rights reserved. Guggenheim, Guggenheim Partners and Innovative Solutions. Enduring Values. are registered trademarks of Guggenheim Capital, LLC.